Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Dec 7, 2012; 18(45): 6635-6644
Published online Dec 7, 2012. doi: 10.3748/wjg.v18.i45.6635
Published online Dec 7, 2012. doi: 10.3748/wjg.v18.i45.6635
UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil
Yan Wang, Jian-Ming Xu, Department of GI Oncology, Cancer Center, 307 Hospital of PLA, Academy of Military Medical Science, Beijing 100071, China
Lin Shen, Department of GI Oncology, Peking University, School of Oncology, Peking University Cancer Hospital and Institute, Beijing 100142, China
Nong Xu, Department of Internal Oncology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Province, China
Jin-Wan Wang, Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Shun-Chang Jiao, Institute of Cancer, Chinese PLA General Hospital, Beijing 100853, China
Ze-Yuan Liu, Clinical Pharmacokinetic laboratory, 307 Hospital of PLA, Academy of Military Medical Science, Beijing 100071, China
Author contributions: Xu JM designed the research; Wang Y performed the research; Shen L, Xu N, Wang JW and Jiao SC contributed the samples and clinical data; all authors analyzed the data; and Xu JM and Wang Y wrote the paper.
Supported by National Natural Science Foundation Project, No. 30971579; the Capital Medical Development Foundation, No. 2007-2029
Correspondence to: Jian-Ming Xu, MD, Department of GI Oncology, Cancer Center, 307 Hospital of PLA, Academy of Military Medical Science, No. 8 Dong Da Street, FengTai District, Beijing 100071, China. jmxu2003@yahoo.com
Telephone: +86-10-51128358 Fax: +86-10-51128358
Received: May 16, 2012
Revised: September 13, 2012
Accepted: October 22, 2012
Published online: December 7, 2012
Revised: September 13, 2012
Accepted: October 22, 2012
Published online: December 7, 2012
Core Tip